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Abstract
Proteases are pivotal modulators of extracellular matrix com-
ponents and bioactive proteins at all phases of cutaneous
wound healing and thereby essentially contribute to the suc-
cessful reestablishment of skin integrity upon injury. As a
consequence, disturbance of proteolytic activity at the wound
site is a major factor in the pathology of chronic wounds. A
large body of data acquired in many years of research pro-
vide a good understanding of how individual proteases may
influence the repair process. The next challenge will be to
integrate these findings and to elucidate the complex inter-
actions of proteolytic enzymes, their inhibitors and substrates
on a system-wide level. Here, we present novel approaches
that might help to achieve this ambitious goal in cutaneous
wound healing research.
Keywords: protease web; proteolysis; proteomics; skin;
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Introduction
Cutaneous wound healing is a highly complex process that
requires precise orchestration of multiple systems involving
different cell types. In order to reestablish the barrier func-
tion of the skin upon injury, a variety of signaling molecules
regulate cell behavior, such as activation, survival and apop-
tosis, differentiation and migration, in a time and space
dependent manner. Mainly the interplay of keratinocytes,
fibroblasts, inflammatory and endothelial cells eventually
leads to wound closure. In a concerted action, these cells are
responsible for essential processes like inflammation, angio-
genesis, granulation tissue formation and reepithelialization
that end in successful wound repair.
The process of wound healing is generally divided into
three overlapping phases: inflammation, new tissue forma-
tion and remodeling (Gurtner et al., 2008). At the beginning
of the first phase, a platelet plug associated with insoluble
fibrin fibers is responsible to achieve hemostasis. A provi-
sional matrix consisting of cross-linked fibrin, fibronectin
and other extracellular matrix (ECM) proteins is formed in
the wound bed and serves as a protective barrier against
water loss and invading bacteria. In addition, this matrix
becomes a scaffold for fibroblasts and endothelial cells and
for infiltrating inflammatory cells, which are attracted to the
site of injury by cytokines, chemokines and inflammatory
mediators. After a few days, the provisional matrix is dis-
entangled from the wound as an eschar. In the second stage,
2–10 days after skin injury, keratinocytes migrate into the
wound and start to proliferate, resulting in wound reepithe-
lialization. The wound clot is gradually replaced by granu-
lation tissue, which is characterized by sprouting blood
vessels, the presence of macrophages and other immune cells
and fibroblasts that deposit ECM. Fibroblasts are attracted
from the undamaged dermis or recruited from the bone mar-
row and activated by growth factors like platelet-derived
growth factor and transforming growth factor b that stimu-
late proliferation and migration. Some fibroblasts differenti-
ate into myofibroblasts, cells responsible for wound
contraction. The final stage of wound repair starts about 2
weeks after injury and lasts up to a year or more. During
this stage of wound maturation, a collagenous scar is formed,
the number of fibroblasts in the wound decreases, and the
number of blood vessels is reduced by apoptosis of endo-
thelial cells. Myofibroblasts and macrophages either undergo
apoptosis or exit the site of injury. The remaining fibroblasts
start to remodel the collagenous dermis and rearrange col-
lagen fibers to optimize tensile strength, which, however,
never recovers the stiffness of unwounded skin. In addition,
healed skin does not contain skin appendages like hair fol-
licles, sweat glands and sebaceous glands.
Proteases play important roles in all phases of cutaneous
wound repair to facilitate invasion of inflammatory cells,
migration of fibroblasts and keratinocytes, formation of new
blood vessels, wound contraction and finally remodeling of
the scar tissue. Thereby, they are not only involved in ECM
degradation, but specifically modify bioactive proteins, such
as chemokines, cytokines and growth factors. Furthermore,
proteases like kinases do not act alone, but are interconnected
in a dynamic network that has been termed the ‘protease
web’ (auf dem Keller et al., 2007). Thus, they are now con-
sidered as pivotal signaling mediators with central roles in
the orchestration of complex processes on the cellular and
on the tissue level during skin wound healing. While many
studies focused on the analysis of matrix metalloproteinases
(MMPs) as classical ‘matrix degraders’, more recent research
started to elucidate MMP activity towards bioactive media-
tors and their impact on wound inflammation and angioge-
nesis (Page-McCaw et al., 2007). In addition, the important
contributions of members of other protease classes, such as
ADAMs (a disintegrin and metalloprotease), astacins (tol-
loids and meprins), cathepsins, kallikreins, and matriptases,
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to the healing process became a particularly active field of
research (Moali and Hulmes, 2009).
In this minireview we will give a short overview of
approaches to assess parameters in protease research in cuta-
neous wound repair with an outlook on how novel technol-
ogies may influence the field in the future. Thereby, we will
focus on the study of proteases in in vivo and in vitro models
of skin repair. For a comprehensive overview of protease
biology in wound healing, taking into account additional data
from the analysis of proteolytic activity in similar processes,
such as inflammation, angiogenesis and carcinogenesis, the
reader is referred to two excellent recent reviews by Toriseva
and Ka¨ha¨ri (2009) and Moali and Hulmes (2009).
Defining the wound transcriptional degradome
A wealth of information is available on the mRNA expres-
sion of proteases at the wound site (transcriptional degra-
dome) and during the time course of the healing process. In
this respect, members of the MMP family have been studied
most extensively due to their implication in all phases of
cutaneous wound repair. Technically, detailed expression data
for most proteases have been acquired using Northern blots,
RNase protection assays and in situ hybridizations in human
and mouse skin wounds (Toriseva and Ka¨ha¨ri, 2009).
Employing these targeted approaches allowed the temporal
and spatial assessment of protease transcripts with high spec-
ificity. While this is an inherent advantage, the analysis of
single transcripts reveals no information about the concom-
itant expression of other proteases that are either directly or
indirectly linked to the protease under study. Addressing this
limitation, some studies monitored the expression of multiple
proteases of the same or of different classes within the same
experiment (Madlener et al., 1998), whereby either predicted
transcriptional linkages between the examined protease genes
could be verified or new relations established. In addition,
the careful selection of samples in human studies and stan-
dardized procedures allows meaningful conclusions when
comparing expression data for individually assessed prote-
ases from independent studies (Toriseva and Ka¨ha¨ri, 2009).
However, transcripts for all proteases and their quantitative
changes at important steps of the repair process should ide-
ally be analyzed in the same experiment. Since this possi-
bility became available with the invention of the cDNA
microarray technology, several studies have applied this tool
to the analysis of cutaneous wound repair (Deonarine et al.,
2007). Although differential expression in wounded versus
normal skin could be corroborated for many proteases, some
previously validated transcripts might evade detection in
microarray analyses. This could be either due to incomplete
transcript coverage of the array used or the generally lower
sensitivity compared to Northern blotting, RNase protection
assay and quantitative real-time (qRT)-PCR. To address the
first issue, dedicated microarrays have been developed for
the study of proteases, the Hu/Mu ProtIn array and the CLIP-
CHIPTM. Due to its unique design the Hu/Mu ProtIn array
allows differential assessment of protease mRNAs from mice
and humans in the same sample and thus is particularly suit-
ed for xenograft studies in mice (Schwartz et al., 2007).
Since this leads to reduced coverage based on the exclusion
of species cross-hybridizations, the CLIP-CHIPTM is the
most comprehensive two-color microarray for proteases,
their inhibitors and inactive homologues (Kappelhoff et al.,
2010). Hence, it provides a valuable and cost-effective alter-
native to high-density exon arrays for the specific analysis
of protease mRNA expression in wound healing. To achieve
comprehensive coverage with concomitant high sensitivity,
profiling of a complete protease class by qRT-PCR has been
proven very useful. Thereby, particular efforts have been
dedicated to the development of specific probes for meas-
uring complete sets of MMP, TIMP (tissue inhibitor of
matrix metalloproteinases), ADAM and ADAMTS (a disin-
tegrin and metalloprotease with thrombospondin motifs)
transcripts in human tumor samples that provide validated
tools also for the study of skin repair (Hodgkinson et al.,
2010; Pennington and Edwards, 2010). In most cases total
RNA for microarray or qRT-PCR analysis was isolated from
tissue lysates neglecting any spatial information for the
measured transcripts within the tissue. However, the latter is
particularly important for the study of processes employing
multiple cell types that dynamically invade and evade the
tissue, such as cutaneous wound healing (Nanney et al.,
2006). An elegant method to gain this information is laser
capture microdissection (LCM) that researchers have suc-
cessfully used to specifically study gene expression in blood
vessels from human wound-edge tissue by microarray anal-
ysis (Roy et al., 2007) or transcripts of CCN genes during
wound healing by qRT-PCR (Rittie´ et al., 2011).
Exploring the wound translational degradome
In many studies the analysis of protease transcript levels and
locations in the wound were complemented by assessment
of expression and cellular distribution of the same proteases
on the protein level, providing a good coverage of the trans-
lational degradome (Madlener et al., 1998). To acquire these
data, mostly Western blot, immunohistochemistry and immu-
nofluorescence techniques were applied, and in some cases
protease proteins were quantified in wound fluids or tissue
lysates by ELISA (Toriseva and Ka¨ha¨ri, 2009). While highly
sensitive and specific, these single protein approaches have
the same limitations as similar techniques for the analysis of
individual transcripts. With their rapid development in recent
years novel mass spectrometry-based proteomics technolo-
gies became attractive alternatives for the identification and
quantification of proteins in complex proteomes. Of these,
both gel-based and gel-free techniques have been applied to
the analysis of wound samples (Edsberg, 2009), whereby
most studies examined wound fluids that can be easily
obtained from patients. In this regard another advantage is
the similarity between wound fluid and blood plasma, for
which numerous depletion strategies for high abundance pro-
teins, such as albumin, have been developed to facilitate the
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discovery of low abundance proteins, which include many
proteases, inhibitors and protease substrates.
In 2008, Fernandez et al. analyzed fluids of chronic human
wounds after immunodepletion of highly abundant compo-
nents by two-dimensional (2D) chromatography and LC-ESI/
MS or MALDI-TOF/TOF. Thereby, they identified about 40
proteins including the protease inhibitor elafin and proteases
of the complement system (Fernandez et al., 2008). In a more
recent study, Eming et al. compared wound fluids derived
from healing and non-healing wounds in a 1D-PAGE LC-
MS/MS approach and identified among 149 total proteins
numerous proteases and inhibitors, such as MMP9, neutro-
phil elastase, plasminogen, plasma kallikrein, serpins and
cystatins (Eming et al., 2010). The most comprehensive list
of 1191 proteins has been reported by Escalante et al. in a
proteomic analysis of wound fluids of mice wounded by
snake venom toxins (Escalante et al., 2009). However, it
should be mentioned that wounds in this study were not a
result of mechanical injury but of intramuscular injection of
toxins. In another study using this model, the same group
also analyzed the effect of batimastat, a broad spectrum
MMP inhibitor, on protein amounts within wound exudates
employing relative quantification by spectral counting.
Indeed, they found a batimastat dependent reduction in
matrix proteins released into the wound fluid indicating inhi-
bition of MMP activity at the wound site (Rucavado et al.,
2011).
However, despite a rapid increase in speed and sensitivity
of newly developed mass spectrometers, the comprehensive
and reliable identification and quantification of all proteases
will most likely be impossible due the overwhelming com-
plexity and dynamic range of protein abundance in wound
fluids or tissues. To circumvent this problem a targeted pro-
teomics technique termed selected reaction monitoring
(SRM) has been established that allows monitoring of spe-
cific proteins in complex proteomes that might be masked in
unbiased discovery approaches (Huttenhain et al., 2009). The
SRM technology has evolved into a high-throughput tech-
nology that enables the simultaneous identification and quan-
tification of hundreds or even thousands of proteins in
biological samples. Hence, it is expected that specific SRM
assays will soon be available to study the expression of pro-
tease classes or even all proteases at important time points
during cutaneous tissue repair. Indeed, according to our own
searches the SRMAtlas (http://www.mrmatlas.org), a com-
pendium for SRM based targeted proteomics assays (Picotti
et al., 2008), currently comprises observed transitions for
66% of all human and 53% of all murine proteases annotated
in the UniProt/Swiss-Prot database.
Obtaining data on the location of expressed proteins within
the heterogeneous wound tissue using mass spectrometry-
based proteomics is even more challenging than in transcrip-
tome analyses, particularly since much higher amounts of
material are needed that cannot easily be obtained by LCM.
However, Wis´niewski et al. recently presented a modified
workflow for shotgun proteomics that allowed the identifi-
cation and quantification of thousands of proteins from
microdissected cancer tissues from clinical specimens, dem-
onstrating the feasibility of this approach (Wisniewski et al.,
2011). Another technique for the spatial analysis of
expressed proteases and substrates in wounds is tissue pro-
filing by MALDI MS, where proteins and peptides are
detected in tissue slices mounted on a MALDI target
(Nanney et al., 2006). Indeed, this technique was success-
fully used to reveal S100 proteins as being differentially
expressed in regenerative versus non-regenerative wounds in
mice (Caldwell et al., 2008).
Taken together, these promising studies indicate the poten-
tial of proteomics to substantially extend our current knowl-
edge of the wound degradome in time and space at the
protein level.
Assessing the wound activity degradome
Since many proteases are tightly regulated not only on the
expression but also on the activity level, the next step in the
degradomics analysis of skin repair is the definition of
the activity degradome, i.e., all expressed proteases that are
active at a given time point after wounding. Gelatin zymo-
graphy has been widely used to assess the activation status
of MMPs in human wound fluids and murine wound lysates.
This technique mainly analyzed the activities of MMP2 and
9, which are highly abundant in wound tissues, potently
degrade gelatin and can be reactivated after treatment with
sodium dodecyl sulfate. Since these proteases are visible on
zymogram gels in both their mature and pro-forms, gelatin
zymography only allows monitoring the amount of poten-
tially active MMP2 and 9 in the sample but provides addi-
tional quantitative information on the zymogens and the
activated enzymes. Alternatively, fluids were incubated with
radioactive collagen as test substrate whose proteolytic proc-
essing was followed by autoradiography with the advantage
that binding of endogenous inhibitors like TIMPs to the pro-
tease is preserved during substrate incubation. Furthermore,
zymography can be applied on tissue sections in form of in
situ zymography providing additional spatial information on
protease activity as demonstrated by analysis of plasmin in
human skin wounds using casein as an artificial substrate.
Still, while powerful for the analysis of a small subset of
wound proteases, zymographic techniques fail to examine
the majority of active proteolytic enzymes after wounding.
Finally, the activity of proteases towards well-defined sub-
strates during wound healing could be visualized by follow-
ing the lack of substrate processing in protease knockout
animals. Examples are the deposition of fibrin in plasmino-
gen deficient mice revealed by immunohistochemistry, the
impaired processing of collagen fibers in MMP9 knockouts
shown by electron microscopy and the reduced degradation
of connective tissue growth factor (CTGF) in mice lacking
MMP13 (Toriseva and Ka¨ha¨ri, 2009).
In recent years, a panel of activity-based probes (ABP) for
several protease classes was developed (Fonovic and Bogyo,
2007) that have been successfully applied to detect active
proteases in tumor samples. To cover more than one protease
this approach was extended by use of probe libraries for
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whole protease classes based on their catalytic mechanism
that allowed activity profiling of more than 20 metallopro-
teases in complex samples. Thereby, the extracted active pro-
teases are identified by mass spectrometry-based proteomics,
opening up a new field of research termed activity-based
protease proteomics that also expands the possibilities to
examine the wound activity degradome. When coupled to
fluorescent moieties ABPs become effective agents for pro-
tease activity imaging in vivo as demonstrated by several
studies analyzing cysteine proteases in tumors. Thereby,
active proteases can be visualized in the living animal and
their tissue distribution subsequently analyzed on tissue sec-
tions. Attractive alternatives to the use of fluorophores as
imaging tags are radioactive tracers, such as w18Fx-labeled
ABPs that could be much easier translated to the clinics.
Such molecules have been developed for MMPs and suc-
cessfully applied to in vivo imaging of breast cancer in mice
(auf dem Keller et al., 2010). One possible application for
this kind of protease activity probes in the field of tissue
repair might be the detection and in situ characterization of
aberrant internal repair processes with help of radioactive
tracer ABPs that are directed against disease associated pro-
teases. Because of the lack of knowledge on extended pro-
tease substrate specificities, to date only a few highly specific
ABPs are available. However, novel powerful proteomics
technologies for the high-throughput characterization of pro-
tease cleavage sites, such as Proteomic Identification of
Cleavage Sites (PICS) (Schilling and Overall, 2008), will
allow developing new ABPs with the potential to more com-
prehensively profile active proteases during wound repair.
Elucidating wound substrate degradomes
An ultimate goal in the examination of proteolysis in wound
healing is the assignment of protein substrates to active pro-
teases, i.e., the determination of the substrate degradome for
each individual proteolytic enzyme, at any given time point
during the repair process. Through many years of magnifi-
cent biochemical research numerous substrates of proteases
known to be active in the healing skin wound have been
identified, whereby mostly in vitro or cell-based assays were
employed. Cleavage of some of these substrates, predomi-
nantly ECM proteins, could be further validated in vivo and
in some cases directly related to the responsible protease by
use of knockout mice or to a protease class by applying
inhibitors directly to the wound site (Toriseva and Ka¨ha¨ri,
2009).
With the rapid advances in quantitative proteomics this
technology became a powerful tool for the identification of
protease substrates that when degraded are substantially
reduced in amount in a protease exposed compared to a con-
trol sample or enriched in cell culture supernatants by pro-
teolytic shedding from the membrane. However, this
approach fails to detect specific cleavages that are respon-
sible for the proteolytic modification of bioactive proteins
and thus the modulation of their activity. To overcome this
limitation various novel techniques have been developed that
enable the selective identification of protein N-termini
(N-terminome) and the assignment of substrates and cleav-
age sites to test proteases (auf dem Keller and Schilling,
2010). This can be achieved by selective labeling of N-ter-
minal protein a-amines using biotinylated reagents and sub-
sequent pullout of N-terminal peptides by avidin affinity
resins following tryptic digest of the sample. Thereby, labels
are transferred after selective blocking of ´-amines in lysine
side chains (N-terminomics) or by use of a modified enzyme
that specifically attacks unprotected protein N-termini. As an
alternative, all primary amines on a protein are labeled, the
sample trypsinated and N-terminal peptides negatively
enriched after removal of internal tryptic peptides either by
sequential chromatography steps (combined fractional diag-
onal chromatography, COFRADIC) or by an amine reactive
polymer in a recently developed method termed terminal
amine isotopic labeling of substrates (TAILS) (Kleifeld et
al., 2010). The use of isotopic tags in TAILS allows differ-
ential labeling of protease exposed and control samples and
thereby discriminating N-termini derived from activity of the
test protease from those generated by basal proteolysis in
native samples based on their quantitative ratios. Further-
more, the modification of TAILS as an iTRAQ (isobaric tags
for relative and absolute quantitation)-based method makes
it a robust platform for the simultaneous quantitative assess-
ment of N-terminomes in up to eight conditions (Prudova et
al., 2010). This is of particular importance when studying
time-resolved processes, such as cutaneous wound healing.
By including knockout animals in a murine wound healing
model and specifically analyzing time points with known
high expression of the protease under study, TAILS or com-
parable techniques should be suitable to identify physiolog-
ical substrates of the test protease in vivo. However, the
overwhelming complexity of the wound proteome and the
often restricted activity of proteases to only small popula-
tions of cells might prevent the detection of these specific
cleavages. Furthermore, the lack of a single protease in
knockout models might lead to perturbations of the proteo-
lytic network resulting in altered protease activities and sub-
strate availabilities that are only secondarily related to the
initial cleavages exerted by the test protease (Kruger, 2009).
As a consequence directly monitoring the differential pro-
cessing of proteins in wild-type and knockout mice could
reveal changes in substrate patterns that do not necessarily
allow conclusions on the primary substrates of the protease
for that corresponding DNA sequences had been deleted
from the genome. Hence, it will be crucial to first identify
these substrates in vitro and then to specifically analyze their
cleavage in vivo, while concomitantly monitoring the general
consequences of lack of the responsible protease on proteo-
lytic activities in the tissue. Therefore, we propose an inte-
grated bottom-up and top-down strategy for the identification
of physiological substrates of a test protease, the analysis of
its influence on the proteolytic network and the elucidation
of novel proteases and their activities implicated in cutaneous
tissue repair (Figure 1). Thereby, secretomes or cell lysates
ideally obtained from primary cells deficient for the test pro-
tease that highly express this enzyme in wild-type wounds
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Figure 1 Strategy to elucidate physiological substrates for a test
protease, its influence on the protease web and novel proteases and
their activities in cutaneous wound healing.
Data from in vitro and cell-based experiments are integrated to
develop targeted SRM assays for multiple candidate substrates that
are monitored in an in vivo wound healing model. Unbiased N-
terminome analyses in combination with microarrays and quantita-
tive proteomics define novel proteases that are subjected to substrate
degradomics.
KO, knockout; WT, wild-type; SRM, selected reaction monitoring;
COFRADIC, combined fractional diagonal chromatography;
TAILS, terminal amine isotopic labeling of substrates.
are first in vitro incubated with the active recombinant pro-
tein or control and subjected to differential analysis of their
N-terminomes. In these experiments inhibitors for proteases
other than the protease under study could be included to
more efficiently discriminate direct targets from proteins
cleaved by proteolytic enzymes activated by the test protease
in the sample. This defines a maximal number of potential
substrates that is narrowed down by complementary experi-
ments, where N-terminomes from wild-type cells are com-
pared to those from knockouts and/or cells overexpressing
the protease of interest. Additionally, information from the
in vitro experiment is used to define if a substrate candidate
that can only be assigned with a high false discovery rate in
this more physiological cell-based setup is included in further
analyses. Both datasets are then combined to define a set of
candidate substrates, for which specific SRM assays are
designed to study their processing in vivo in the presence
and absence of the test protease by specifically monitoring
the cleavage site. The integration of these results with data
obtained from unbiased multiplex N-terminome analyses of
samples from wild-type and knockout animals finally deter-
mines parameters for novel substrate candidates that can only
be observed in vivo. Furthermore, these data reveal pertur-
bations to the protease web during wound repair that in com-
bination with microarray and quantitative proteomics
analyses identify novel proteases that are analyzed for their
substrate degradomes as described above.
Conclusions
A tremendous body of work has established proteases as piv-
otal players in all phases of wound repair. Thereby, they have
been identified as important modifiers of the extracellular
matrix in reepithelialization and remodeling and more recent-
ly also as modulators of multiple signaling pathways by spe-
cific processing of bioactive proteins. Most importantly,
aberrant proteolytic activity has been strongly associated
with the pathogenesis of chronic wound healing that affects
the quality of life of many individuals and puts a significant
burden on the health systems. Since proteases do not act
alone but form a complex interaction network, it will be
crucial to systematically determine their expression, activity
and substrates at multiple time points of the repair process.
Thereby, novel system-wide approaches as described in this
minireview open up new possibilities to address this chal-
lenging task and have the potential to identify new targets to
therapeutically interfere with causes for aberrant skin repair.
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